RO7017773: Clinical Trials

1 trial of RO7017773, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow RO7017773: new trials by email Literature Review of RO7017773 trials Research Report on RO7017773

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 12-Week Placebo-Controlled Study to Investigate the Efficacy, Safety, and Tolerability of RO7017773 in Participants Aged 15-45 Years With Autism Spectrum Disorder (ASD)
Placebo, RO7017773 - Autism Spectrum Disorder (ASD)
Phase 2CompletedHoffmann-La Roche1042021-03-312025-01-28

Conditions studied

Autism Spectrum Disorder (1)

Sponsors

Hoffmann-La Roche (1)

Countries

Canada (1)  ·  Italy (1)  ·  Spain (1)  ·  United States (1)

NIH funding

2019 (1)